Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countries.
Journal: The Journal of antimicrobial chemotherapy
Published: December 07, 2017
Five-Year Summary of In Vitro Activity and Resistance Mechanisms of Linezolid against Clinically Important Gram-Positive Cocci in the United States from the LEADER Surveillance Program (2011 to 2015).
Journal: Antimicrobial agents and chemotherapy
Published: March 24, 2017
ZAAPS Program results for 2015: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 32 countries.
Journal: The Journal of antimicrobial chemotherapy
Published: March 07, 2017
Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies.
Journal: Mycoses
Published: February 01, 2017
Surveillance for linezolid resistance via the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) programme (2014): evolving resistance mechanisms with stable susceptibility rates.
Journal: The Journal of antimicrobial chemotherapy
Published: December 02, 2015
Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014).
Journal: Antimicrobial agents and chemotherapy
Published: November 17, 2015
Update on linezolid in vitro activity through the Zyvox Annual Appraisal of Potency and Spectrum Program, 2013.
Journal: Antimicrobial agents and chemotherapy
Published: February 04, 2015
In vitro activity of linezolid as assessed through the 2013 LEADER surveillance program.
Journal: Diagnostic microbiology and infectious disease
Published: October 14, 2014
Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data.
Journal: The Journal of antimicrobial chemotherapy
Published: June 13, 2014
Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) program: report of linezolid activity over 9 years (2004-12).
Journal: The Journal of antimicrobial chemotherapy
Published: January 29, 2014
Summary of linezolid activity and resistance mechanisms detected during the 2012 LEADER surveillance program for the United States.
Journal: Antimicrobial agents and chemotherapy
Published: December 11, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026